Document Detail


Nanomedicine in cardiovascular therapy: recent advancements.
MedLine Citation:
PMID:  22894635     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Cardiovascular disease (CVD) is comprised of a group of disorders affecting the heart and blood vessels of the human body and is one of the leading causes of death worldwide. Current therapy for CVD is limited to the treatment of already established disease, and it includes pharmacological and/or surgical procedures, such as percutaneous coronary intervention with stenting and coronary artery bypass grafting. However, lots of complications have been raised with these modalities of treatment, including systemic toxicity with medication, stent thrombosis with percutaneous coronary intervention and nonsurgical candidate patients for coronary artery bypass grafting. Nanomedicine has emerged as a potential strategy in dealing with these obstacles. Applications of nanotechnology in medicine are already underway and offer tremendous promise. This review explores the recent developments of nanotechnology in the field of CVD and gives an insight into its potential for diagnostics and therapeutics applications. The authors also explore the characteristics of the widely used biocompatible nanomaterials for this purpose and evaluate their opportunities and challenges for developing novel nanobiotechnological tools with high efficacy for biomedical applications, such as radiological imaging, vascular implants, gene therapy, myocardial infarction and targeted delivery systems.
Authors:
Ziyad Mohammed Binsalamah; Arghya Paul; Satya Prakash; Dominique Shum-Tim
Related Documents :
19801505 - Cardiac t2* magnetic resonance for prediction of cardiac complications in thalassemia m...
16670115 - Efficacy of patient activated antitachycardia pacing therapy using the medtronic at500 ...
7004155 - Cardioversion and defibrillation.
21859785 - Laser fluorescence angiography reveals perfusion defects in retrograde cardioplegia.
2909565 - Effects of ventricular fibrillation and defibrillation on pacing threshold in the anest...
23418095 - Effects of an environmentally relevant polychlorinated biphenyl (pcb) mixture on embryo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  10     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-08-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  805-15     Citation Subset:  IM    
Affiliation:
Divisions of Cardiac Surgery and Surgical Research, McGill University Health Center, Montreal, Québec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adiposopathy and thyroid disease: tracing the pathway to cardiovascular risk.
Next Document:  Quality of discharge summaries prepared by first year internal medicine residents.